Donate
info@cureduchenne.org(949) 872-2552
COVID-19 Resources
EventsContact
Cart
×

No products in the cart.

Shop Now
CureDuchenne
Moble Nav Icon
  • Cure
    • CureDuchenne Link
    • Research Overview
    • Research Terms
    • Exon Skipping
    • Clinical Trials
  • Care
    • COVID-19 Resources
    • Newly Diagnosed
    • Clinic
    • Steroid Use
    • Emergency Care
    • Resource Library
    • DME Guide
    • Medical ID Bracelets
    • Navigating School
    • Occupational Therapy
    • Physical Therapy
    • For Families
    • - Find a Physical Therapist
    • - Pool Activities
    • - Stretching
    • For Physical Therapists
    • - PT Certification
    • - Professional Courses
    • For Clinics
  • Community
    • CureDuchenne CARES
    • CureDuchenne FUTURES
    • CureDuchenne Champions
    • DuchenneXchange
    • Family Stories
    • Events
    • Previous Webinars
    • Family Fundraisers
  • About Us
    • Mission
    • Vision
    • About Duchenne
    • Team
    • Blog
    • Board of Directors
    • Scientific Advisory Board
    • Sponsors
    • Events & Webinars
    • News Center
    • - Press Releases
    • - Partner News
  • CD Ventures
    • About CD Ventures
    • Our Impact
  • Get Involved
    • Donate
    • More Ways to Give
    • Fundraise
    • Shop
    • Fundraising Events
    • - Dealing for Duchenne | San Antonio, TX
    • - Getzlaf Golf Shootout | Orange County, CA
    • - Napa in Newport | Orange County, CA
  • Donate
  • All
  • CureDuchenne Blog
  • Press Releases
  • Partner News
  • Media Mention

CureDuchenne Ventures Invests in hC Bioscience and its Novel tRNA-Based Therapeutic Approach for Duchenne Muscular Dystrophy

February 28, 2023

CureDuchenne Ventures Invests in hC Bioscience and its Novel tRNA-Based Therapeutic Approach for Duchenne Muscular Dystrophy

Read More

Protected: TRIAL OPPORTUNITY

February 23, 2023

There is no excerpt because this is a protected post.

Read More

New cTAP Evidence Supports Patient-Centric Alternatives

February 7, 2023

CureDuchenne was the original funder of cTAP. We congratulate the consortium and other authors on their recent publication looking at large data sources and investigating effects of different genotypes on […]

Read More

CureDuchenne Congratulates Myosana on Closing its Latest Round of Funding

January 24, 2023
Myosana Therapeutics, a biotech company based in Seattle, WA, closed a new $5 million financing round to support further development of their non-viral gene therapy technology for the treatment of [...]
Read More

Entrada Announces Selection of Second Clinical Trial Candidate

January 12, 2023

Entrada Therapeutics announced the selection of a second clinical candidate, ENTR-601-45, for the potential treatment of people living with Duchenne who are exon 45 skipping amenable. Read more in the […]

Read More

Santhera and ReveraGen Complete NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy 

October 27, 2022

 Pratteln, Switzerland, and Rockville, MD, USA, October 27, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce that they have completed the rolling submission of a new drug […]

Read More

Edgewise Therapeutics announces six sites are open for enrollment for the Canyon trial

October 18, 2022

We are pleased to announce that six sites are open for enrollment for the Canyon trial for individuals living with Becker Muscular Dystrophy! Canyon is a Phase 2 trial of […]

Read More

PepGen Presents Data from its Duchenne Muscular Dystrophy Program at World Muscle Society Congress

October 14, 2022

See full PRESS RELEASE: https://www.globenewswire.com/news-release/2022/10/13/2534198/0/en/PepGen-Presents-Data-from-its-Duchenne-Muscular-Dystrophy-Program-at-World-Muscle-Society-Congress.html

Read More

Dyne Therapeutics Presents Preclinical Data from its Duchenne Muscular Dystrophy Programs Targeting Exons 51 and 53 at World Muscle Society 2022 Congress

October 14, 2022

Dyne Therapeutics, who received early funding from CureDuchenne, presented promising preclinical data from their Duchenne Exon 51 and 53 programs at the World Muscle Society Congress.  This was Dyne’s first […]

Read More
  • 1
  • 2
  • 3
  • …
  • 27
  • Next Page »
  • About

    • Mission
    • About Duchenne MD
    • Team
    • Blog
    • Store
  • Get Involved

    • Donate
    • Fundraising
    • Attend an Event
  • CureDuchenne

    • 100 Bayview Circle, Suite 5600
      Newport Beach, CA 92660
      (949) 872-2552
      info@cureduchenne.org

  • Get Connected

PRIVACY POLICY | TERMS OF USE | INDIRECT COST POLICY | TAX INFO

CureDuchenne is a 501c3 registered tax-exempt nonprofit organization. Federal Tax ID: #20-0299958 | ©2023 CureDuchenne. All rights reserved.

Please be advised that the contents within the CureDuchenne site include a compilation of articles, advisements, and references from the community. CureDuchenne does not provide medical advice nor is CureDuchenne a medical provider. The intent of this shared content is to serve as a point of reference for informational purposes. Please refer to your health care provider(s) for your individualized, specific care management needs. The CureDuchenne website may contain links to external websites that are not provided and/or maintained by or in any way affiliated with CureDuchenne. CureDuchenne recommends that you review the terms of service and privacy policies of these external websites before entering. Please note that CureDuchenne does not guarantee the accuracy, relevance, timeliness, or completeness of any information on these external websites.

Newsletter signup

Sign up to receive news, updates, and announcements about CureDuchenne topics.

"*" indicates required fields

Area of interest*
Consent*
*
By clicking the SIGN UP, I agree to abide by the privacy policy.

Stay informed

Sign up to receive news, updates, and announcements about CureDuchenne topics.

"*" indicates required fields

Area of interest*
Consent*
*
By clicking the SIGN UP, I agree to abide by the privacy policy.

Stay informed

Sign up to receive news, updates, and announcements about CureDuchenne topics.

"*" indicates required fields

Area of interest*
Consent*
*
By clicking the SIGN UP, I agree to abide by the privacy policy.

Our Spring Sale Has Started

You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/

We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you are agreeing to accept our use of cookies. For more information about cookies please visit our Privacy Policy page.I Agree